Colorectal, Cancer Clinical Trials in Beijing
8 recruitingBeijing, China
Showing 1–8 of 8 trials
Recruiting
Phase 1Phase 2
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
Colorectal, CancerHead and Neck CancerNon-small Cell Lung Cancer+1 more
Betta Pharmaceuticals Co., Ltd.400 enrolled87 locationsNCT04930432
Recruiting
Phase 1
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Colorectal, CancerNon-small Cell Lung CancerPancreatic Ductal Adenocarcinoma
Eli Lilly and Company630 enrolled52 locationsNCT06586515
Recruiting
Phase 2
Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal Cancer
Colorectal, Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences36 enrolled1 locationNCT06405139
Recruiting
Phase 1
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
Breast Cancer FemaleColorectal, CancerPancreatic Cancer+4 more
UTC Therapeutics Inc.24 enrolled1 locationNCT06256055
Recruiting
Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery
Colorectal, Cancer
Xi Shan Wang3,060 enrolled22 locationsNCT03349762
Recruiting
Phase 2
PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC
Colorectal, CancerColorectal NeoplasmsRAS Mutation+1 more
Chinese PLA General Hospital40 enrolled1 locationNCT06206096
Recruiting
Phase 2
KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer
Colorectal, Cancer
Peking University Cancer Hospital & Institute98 enrolled1 locationNCT05985109
Recruiting
the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
Colorectal, Cancer
Ding Ke-Feng55,000 enrolled5 locationsNCT04074538